FDA sends warning letter to Philips due to quality issues
The Food and Drug Administration sent a warning letter to Philips last month due to quality violations found at three of its medical device facilities earlier this year. The letter, dated Sept. 9, highlights nine violations found at the facilities, located in Washington, Pennsylvania and the Netherlands. The FDA urged Philips to investigate and determine the causes of the violations and take swift action to bring impacted products into compliance.
Related News Articles
Headline
The AHA Aug. 31 joined a coalition led by LeadingAge and other national healthcare organizations in submitting comments to the Centers for Medicare &…
Headline
The Federal Office of Rural Health Policy’s Rural Health Redesign Center will host a webinar on Sept. 24 at 2 p.m. ET, where hospital CEOs will discuss the…
Headline
In this conversation, Caroline DeLongchamps, director of the patient- and family-centered care program at MUSC Health, shares a powerful personal story and…
Headline
The AHA Aug. 11 published a new issue brief on how hospitals and health systems can incorporate care navigation and coordination into their patient care…
Headline
Two individuals have died in Michigan in connection to the current multistate cyclosporiasis outbreak, the Michigan Department of Health and Human Services…
Headline
The AHA’s Living Learning Network, in partnership with the Centers for Disease Control and Prevention, July 22 released “Rural Sepsis Care in Action: Real-…